J. Goldman & CO LP Karuna Therapeutics, Inc. Transaction History
J. Goldman & CO LP
- $3.27 Billion
- Q2 2024
A detailed history of J. Goldman & CO LP transactions in Karuna Therapeutics, Inc. stock. As of the latest transaction made, J. Goldman & CO LP holds 4,100 shares of KRTX stock, worth $0. This represents 0.06% of its overall portfolio holdings.
Number of Shares
4,100Holding current value
$0% of portfolio
0.06%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding KRTX
# of Institutions
10Shares Held
332KCall Options Held
0Put Options Held
0-
Pictet Asset Management Sa Geneva 73, V8213KShares$00.06% of portfolio
-
Tekla Capital Management LLC58.6KShares$00.5% of portfolio
-
International Biotechnology Trust PLC London, X030.5KShares$01.75% of portfolio
-
Ea Series Trust Havertown, PA12.8KShares$00.1% of portfolio
-
Brinker Capital Investments, LLC6.1KShares$00.02% of portfolio
About Karuna Therapeutics, Inc.
- Ticker KRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 33,965,000
- Description
- Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...